Home/Filings/4/0000899243-23-002611
4//SEC Filing

Kuriakose Emil 4

Accession 0000899243-23-002611

CIK 0001496671other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 4:00 PM ET

Size

5.3 KB

Accession

0000899243-23-002611

Insider Transaction Report

Form 4
Period: 2023-01-23
Kuriakose Emil
CHIEF MEDICAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2023-01-23$0.45/sh79$353,539 total
Footnotes (3)
  • [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
  • [F3]Includes 125 shares acquired on each of June 10, 2022 and December 9, 2022, under the Company's 2014 Employee Stock Purchase Plan.

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1
  • filerCIK 0001892413

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:00 PM ET
Size
5.3 KB